Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomized, double blind, placebo-controled trial
Rev. pediatr. electrón
;
15(4): 2-3, dic. 2018.
Article
in Spanish
| LILACS
| ID: biblio-998379
Subject(s)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Aspirin
/
Myocardial Infarction
Type of study:
Controlled clinical trial
/
Etiology study
/
Risk factors
Limits:
Humans
Language:
Spanish
Journal:
Rev. pediatr. electrón
Journal subject:
Pediatrics
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS